Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank67
3Y CAGR+32.0%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+32.0%/yr
Annual compound
Percentile
P67
Within normal range
vs 3Y Ago
2.3x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $8.60M | -31.7% |
| 2024 | $12.60M | -18.7% |
| 2023 | $15.49M | +314.3% |
| 2022 | $3.74M | +171.3% |
| 2021 | $-5.24M | -60.1% |
| 2020 | $-3.27M | -1921.6% |
| 2019 | $-162000.00 | - |